Hypomagnesemia in patients with type 2 diabetes

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 2, 2007, Pages 366-373

  Pham, Phuong Chi T ^a   Pham, Phuong Mai T ^b   Pham, Son V ^c   Miller, Jeffrey M ^a   Pham, Phuong Thu T ^d  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

BLOOD; HUMAN; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; MAGNESIUM; METABOLIC DISEASES;

EID: 34548835794     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02960906     Document Type: Short Survey

References (80)

1. American Diabetes Association: National Diabetes Fact Sheet, Alexandria, VA, ADA, 2002. Available at: http://www.diabetes.org/ diabetes-statistics. Accessed February 21, 2005
2. Sanders GT, Huijgen HJ, Sanders R: Magnesium in disease: A review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 37: 1011-1033, 1999
3. Saris NEL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A: Magnesium: An update on physiological, clinical and analytical aspects. Clin Chem Acta 294: 1-26, 2000
4. Elamin A, Tuvemo T: Magnesium and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 10: 203-209, 1990
5. White JR, Campbell RK: Magnesium and diabetes: A review. Ann Pharmacother 27: 775-780, 1993
6. Sales CR, de Fatima Campos Pedrosa L: Magnesium and diabetes mellitus: Their relation. Clin Nutr 25: 554-562, 2006
7. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, Yanagawa N, Pham PT: Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol 63: 429-436, 2005 [published erratum appears in Clin Nephrol 64: 248, 2005]
8. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I: Renal hypomagnesaemia in human diabetes mellitus: Its relation to glucose homeostasis. Eur J Clin Invest 12: 81-85, 1982
9. Tosiello L: Hypomagnesemia and diabetes mellitus. Arch Intern Med 156: 1143-1148, 1996
10. Mather H, Nisbet JA, Burton GH, Poston GJ, Bland JM, Bailey PA, Pilkington TR: Hypomagnesemia in diabetes. Clin Chim Acta 95: 235-242, 1979
11. De Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V: The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21: 682-686, 1998
12. Walti MK, Zimmermann MB, Spinas GA, Hurrell RF: Low plasma magnesium in type 2 diabetes. Swiss Med Wkly 133: 289-292, 2003
13. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48: 927-940, 1995
14. Sheehan JP: Magnesium deficiency and diabetes mellitus. Magnes Trace Element 10: 215-219, 1991-1992
15. Mikhail N, Ehsanipoor K: Ionized serum magnesium in type 2 diabetes mellitus: Its correlation with serum magnesium and hemoglobin A1C levels. South Med J 92: 1162-1166, 1999
16. Sjogren AS, Floren CH, Nilsson A: Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35: 459-463, 1986
17. Pon KK, Ho PWM: Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus. Diabetes Res Clin Pract 7: 163-167, 1989
18. Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, D'Onofrio F: Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 55: 1161-1167, 1992
19. Resnick L, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM: Intracellular and extracellular magnesium depletion in type 2 (non-insulin-independent) diabetes mellitus. Diabetologia 36: 767-770, 1993
20. Kao WH, Folsom AR, Nieto J, Mo JP, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus. The Atherosclerosis Risk in Communities study. Arch Intern Med 159: 2151-2159, 1999
21. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27: 134-140, 2004
22. Song Y, Manson JE, Buring JE, Liu S: Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27: 59-65, 2004
23. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR: Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29: 2238-2243, 2006
24. Nadler J, Buchanan T, Natarajan R, Antoipitlai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21: 1024-1029, 1993
25. Rodriguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 26: 1147-1152, 2003
26. Dzurik R, Stetikova K, Spustova V, Fetkovska N: The role of magnesium deficiency in insulin resistance: An in vitro study. J Hypertens 9[Suppl 6]: S312-S313, 1991
27. Grafton G, Baxter MA: The role of magnesium in diabetes mellitus. J Diabetes Complications 6: 143-149, 1992
28. Durlach J, Altura B, Altura BM: Highlights and summary of the 10th annual French Colloquium on Magnesium. Magnesium 2: 330-336, 1983
29. Tonyai S, Motto C, Rayssiguer Y, Heaton FW: Erythrocyte membrane in magnesium deficiency [Abstract]. Am J Nutr 4: 399, 1985
30. Garber AJ: Magnesium utilization survey in selected patients with diabetes. Clin Ther 18: 285-294, 1996
31. Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G: Hypomagnesemia in type 2 diabetes mellitus is not corrected by improvement of long term control. Diabetologia 35: 77-79, 1992
32. Eibl NL, Koppe HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G: Hypomagnesemia in type 2 diabetes: Effect of a 3-month replacement therapy. Diabetes Care 18: 188-192, 1995
33. Rayssignier Y: Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 3: 226-238, 1984
34. Shivakumar K: Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system. Magnes Res 15: 307-315, 2002
35. Kurantsin-Mills J, Cassidy MM, Stafford RE, Weglicki WB: Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat model. Br J Nutr 78: 845-855, 1997
36. Maier JAM, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A: Low magnesium promotes endothelial cell dysfunction: Implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689: 13-21, 2004
37. Zhou Q, Olinescu RM, Kummerow FA: Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells. Magnes Res 12: 19-29, 1999
38. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S: Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 238: 163-179, 2002
39. Altura BM, Altura BT, Gehrewold A, Ising H, Gunther T: Magnesium deficiency and hypertension: Correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 223: 1315, 1984
40. Rude R, Manoogian C, Ehrlich L, De Russo PD, Ryzen E, Nadler J: Mechanisms of blood pressure regulation by magnesium in man. Magnesium 8: 266, 1989
41. Fakunding JL, Chow R, Catt KJ: The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II, and potassium in isolated glomerulosa cells. Endocrinology 105: 327-333, 1979
42. Ichihara A, Suzuki H, Saruta T: Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. J Lab Clin Med 122: 432-440, 1993
43. Hartwig A: Role of magnesium in genomic stability. Mutat Res 475: 113-121, 2001
44. Resnick LM, Gupta RK, Gruenspan H, Laragh JH: Intracellular free magnesium in hypertension: Relation to peripheral insulin resistance. J Hypertens 6[Suppl 4]: s199-s201, 1988
45. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 136: 480-490, 1998
46. McNair P, Christiansen C, Modibad S, Binder C: Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27: 1075-1077, 1978
47. Hatwal A, Gujral AS, Bhatia RPS, Agrawal JK, Bajpai HS: Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol 67: 714-716, 1989
48. Rodriguez-Moran M, Guerrero-Romero F: Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 32: 300-303, 2001
49. Corsonello A, Lentile R, Buemi M, Cucinotta D, Mauro VN, Macaione S, Corica F: Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 20: 187-192, 2000
50. Quamme GA: Renal handling of magnesium. In: Massry and Glassock's Textbook of Nephrology, 4th Ed., edited by Massry SH, Glassock RJ, Baltimore, Lippincott Williams & Wilkins, 2001, pp 344-350
51. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG: TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 279: 19-25, 2004
52. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M: Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31: 166-170, 2002
53. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC: Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31: 171-174, 2002
54. Quamme GA, Dirks JH: The physiology of renal magnesium handling. Ren Physiol 9: 257, 1986
55. Quamme GA: Control of magnesium transport in the thick ascending limb. Am J Physiol 256: F197-F210, 1989
56. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP: Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285: 103-106, 1999
57. Weber S, Hoffmann K, Jeck N, Saar K, Boeswald M, Kuwertz-Broeking E, Meij II, Knoers NV, Cochat P, Sulakova T, Bonzel KE, Soergel M, Manz F, Schaerer K, Seyberth HW, Reis A, Konrad M: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8: 414-422, 2000
58. Mandon B, Siga E, Chabardes D, Firsov D, Roinel N, De Rouffignac C: Insulin stimulates Na+, Cl-, Ca2+ and Mg2+ transports in TAL of mouse nephron: Cross-potentiation with AVP. Am J Physiol 265: F361-F369, 1993
59. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A: LTRPC7 is a Mg·ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001
60. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A: TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol 121: 49-60, 2003
61. Quamme GA: Renal magnesium handling: New insights into old problems. Kidney Int 52: 1180-1195, 1997
62. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DEC, Quamme GA: Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81: 51-81, 2001
63. Quamme GA, Dai LJ: Presence of a novel influx pathway for Mg2+ in MDCK cells. Am J Physiol 259: C521-C525, 1990
64. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ: The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol 17: 1035-1043, 2006
65. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D: American Diabetes Association. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 28: 956-962, 2005
66. Lee C-T, Lien Y-HH, Lai L-W, Chen J-B, Lin C-R, Chen H-C: Increased renal calcium and magnesium transporter abundance in streptozotocin-induced diabetes mellitus. Kidney Int 69: 1786-1791, 2006
67. Dai LJ, Friedman PA, Quamme GA: Cellular mechanisms of chlorothiazide and potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells. Kidney Int 51: 1008-1017, 1997
68. Dai LJ, Friedman PA, Quamme GA: Phosphate depletion diminishes Mg2+ uptake in mouse distal convoluted tubule cells. Kidney Int 51: 1710-1718, 1997
69. Wong NLM, Quamme GA, O'Callaghan TJ, Sutton RAL, Dirks JH: Renal and tubular transport in phosphate depletion: A micropuncture study. Can J Physiol Pharmacol 58: 1063-1071, 1980
70. Dai LJ, Friedman PA, Quamme GA: Acid-base changes alter Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol Renal Physiol 272: F759-F766, 1997
71. Nijenhuis T, Renkema KY, Hoenderop JG, Bindels RJ: Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol 17: 617-626, 2006
72. Duarte CG: Effects of chlorothiazide and amipramizide (MK 870) on the renal excretion of calcium, phosphate and magnesium. Metabolism 17: 420-429, 1968
73. Eknoyan G, Suki WN, Martinez-Maldonado M: Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs. J Lab Clin Med 76: 257-266, 1970
74. Hodler J, Roulin F, Haldimann B: Short-term effect of thiazides on magnesium and calcium metabolism and secondarily on that of phosphorus, uric acid, oxalate and cyclic AMP [in French]. Nephrologie 4: 60-63, 1983
75. Dai LJ, Raymond L, Friedman PA, Quamme GA: Mechanisms of amiloride stimulation of Mg2+ uptake in immortalized mouse distal convoluted tubule cells. Am J Physiol Renal Physiol 272: F249-F256, 1997
76. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ: Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115: 1651-1658, 2005
77. Tong GM, Rude RK: Magnesium deficiency in critical illness. J Intensive Care Med 20: 3-17, 2005
78. O'Donovan D, Feinle-Bisset C, Jones K, Horowitz M: Idiopathic and diabetic gastroparesis. Curr Treat Options Gastroenterol 6: 299-309, 2003
79. Smith DS, Ferris CD: Current concepts in diabetic gastroparesis. Drugs 63: 1339-1358, 2003
80. Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 61: 833-839, 2005